IRWD - Ironwood Pharmaceuticals, Inc.
NEXT EARNINGS:
Feb 26, 2026
(in 1 day)
EPS Est: $0.02
Price:
--
--
|
CONSENSUS:
Hold
DETAILS
|
PRICE TARGET:
$5.35
DETAILS
HIGH:
$5.70
LOW:
$5.00
MEDIAN:
$5.35
CONSENSUS:
$5.35
UPSIDE:
41.16%
Market Cap:
616.55M
Volume:
3,545,249
Avg Volume:
4,172,626
52 Week Range:
0.53-5.78
Sector:
Healthcare
Industry:
Drug Manufacturers - Specialty & Generic
Beta:
0.19
Last Dividend:
$N/A
Exchange:
NASDAQ
Country:
US
Employees:
253
IPO Date:
2010-02-03
EPS (TTM):
0.01
P/E Ratio:
800.84
Revenue (TTM):
351.41M
Total Assets:
350.91M
Total Debt:
599.48M
Cash & Equiv:
88.56M
Rev Growth (5Y):
-3.9%
EPS Growth (5Y):
-69.9%
FCF Growth (5Y):
96.4%
ROCE:
30.7%
Debt/Equity:
-1.99
Earnings History
| Date | EPS Actual | EPS Est | EPS Surprise | Rev Actual | Rev Est | Rev Surprise |
|---|---|---|---|---|---|---|
| 2025-11-10 | $0.24 | $0.09 | +166.7% | $122.1M | $50.9M | +139.6% |
| 2025-08-07 | $0.14 | $-0.02 | +800.0% | $85.2M | $77.8M | +9.5% |
| 2025-05-07 | $-0.14 | $-0.05 | -180.0% | $41.1M | $71.0M | -42.1% |
| 2025-02-27 | $0.02 | $0.10 | -80.0% | $90.5M | $67.0M | +35.1% |
| 2024-11-07 | $0.02 | $0.08 | -75.0% | $91.6M | $92.5M | -1.0% |
| 2024-08-08 | $-0.01 | $0.15 | -103.6% | $94.4M | $107.0M | -11.8% |
| 2024-05-09 | $-0.02 | $0.18 | -111.1% | $74.9M | $105.8M | -29.2% |
| 2024-02-15 | $-0.01 | $0.21 | -104.8% | $117.6M | $117.5M | 0.0% |
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 351.41M | 442.74M | 410.60M | 413.75M | 389.52M | 428.41M | 346.64M | 298.28M | 273.96M | 149.56M | 76.44M | 22.88M |
| Net Income | 880,000 | (1.00B) | 175.06M | 528.45M | 106.18M | 21.50M | (282.37M) | (116.94M) | (81.71M) | (142.67M) | (189.62M) | (272.81M) |
| EPS | 0.01 | -6.45 | 1.13 | 3.26 | 0.67 | -0.10 | -1.85 | -0.79 | -0.56 | -1.00 | -1.39 | -2.35 |
| Total Assets | 350.91M | 471.07M | 1.10B | 1.13B | 559.24M | 402.75M | 332.05M | 605.67M | 709.82M | 619.12M | 333.51M | 278.96M |
| Total Debt | 599.48M | 715.54M | 415.92M | 475.80M | 453.70M | 431.22M | 413.92M | 400.17M | 372.80M | 381.49M | 177.32M | 178.94M |
| Cash & Equivalents | 88.56M | 92.15M | 656.20M | 620.13M | 364.30M | 177.02M | 173.17M | 125.74M | 54.00M | 261.29M | 74.30M | 75.49M |
| Operating Cash Flow | 103.55M | 183.43M | 273.76M | 261.89M | 168.84M | 10.72M | (70.88M) | (99.56M) | (25.43M) | (106.93M) | (155.57M) | (273.36M) |
| Free Cash Flow | 103.41M | 183.15M | 273.63M | 261.63M | 166.99M | 3.54M | (79.50M) | (103.77M) | (129.64M) | (110.98M) | (159.11M) | (282.95M) |
| FCF per Share | 0.65 | 1.18 | 1.77 | 1.61 | 1.05 | 0.02 | -0.52 | -0.70 | -0.89 | -0.78 | -1.16 | -2.44 |
| Book Value | (301.33M) | (346.30M) | 652.38M | 605.91M | 62.64M | (93.25M) | (196.37M) | 9.85M | 66.72M | 95.12M | 88.55M | 38.23M |
| Cash & ST Investments | 88.56M | 92.15M | 656.20M | 620.13M | 364.30M | 177.02M | 173.17M | 221.42M | 305.22M | 439.39M | 248.33M | 197.60M |
| ROC Equity | N/A | N/A | 0.27 | 0.87 | 1.70 | N/A | N/A | -11.87 | -1.22 | -1.50 | -2.14 | -7.14 |